Gelesis Holdings, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
GLSHQ, GLSWQ on OTC
Industry
Pharmaceutical Preparations
Location
501 Boylston Street, Suite 6102, Boston, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Gelesis Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Raju S. Kucherlapati Director Nov 18, 2022
Ssd2, Llc 10%+ Owner Jan 13, 2022
Elliot Maltz Chief Financial Officer May 6, 2022
Yishai Zohar President & CEO, Director May 6, 2022
David Abraham General Counsel May 6, 2022
PureTech Health plc 10%+ Owner Sep 20, 2023
Elaine Chiquette Chief Scientific Officer Jun 8, 2022
Clayton Christopher Director May 6, 2022
Dominic Perks Director May 6, 2022
Alison Bauerlein Director May 6, 2022
David A. Pass Chief Operating Officer May 6, 2022
Paul R. Fonteyne Director May 6, 2022
Harry L. Leider Chief Medical Officer May 6, 2022
Kathryn Cavanaugh Director May 6, 2022
HPSO SPV Ltd 10%+ Owner Jan 13, 2022
Jane Wildman Director May 6, 2022
Alessandro Sannino Lead Project Scientist Jun 8, 2022

Recent Insider Transactions by Companies or Individuals for Gelesis Holdings, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership